Core Insights - Palisade Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for autoimmune, inflammatory, and fibrotic diseases [3] Group 1: Presentation Announcement - Palisade Bio announced that its abstract has been accepted for poster presentation at the Crohn's & Colitis Congress scheduled for February 6-8, 2025, in San Francisco, CA [1] - The poster presentation will focus on PALI-2108, a colon-specific PDE4B inhibitor prodrug that is activated in the colon and reduces ulcerative colitis symptoms in an acute colitis DSS mouse model [2] Group 2: Presentation Details - The poster session will take place on February 7, 2025, from 5:00 PM to 6:30 PM PST at the Exhibition Hall, Level 1, Moscone West [2] - For further information about the congress, interested parties can visit crohnscolitiscongress.org [2]
Palisade Bio Selected for Poster Presentation at the 2025 Crohn's & Colitis Congress